Xtrackers Stoxx Europe 600 UCITS ETF 1C | XSX6Register to Unlock Ratings |
Performance History | 30/04/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 3.6 | 17.4 | -5.4 | 13.3 | 5.1 | |
+/-Cat | -0.7 | 2.0 | 2.9 | 1.7 | 0.4 | |
+/-B’mrk | 1.0 | -0.3 | -0.9 | 0.1 | -0.1 | |
Category: Europe Large-Cap Blend Equity | ||||||
Category Benchmark: Morningstar DM Eur TME NR EUR |
Key Stats | ||
Closing Price 01/05/2024 | EUR 123.26 | |
Day Change | 0.03% | |
Morningstar Category™ | Europe Large-Cap Blend Equity | |
Volume | 13952 | |
Exchange | DEUTSCHER KASSENVEREIN AG GRUPPE DEUTSCHE BOERSE | |
ISIN | LU0328475792 | |
Fund Size (Mil) 30/04/2024 | EUR 2552.04 | |
Share Class Size (Mil) 30/04/2024 | EUR 2397.87 | |
Ongoing Charge 15/02/2024 | 0.21% |
Morningstar Research |
Investment Objective: Xtrackers Stoxx Europe 600 UCITS ETF 1C | XSX6 |
The aim is for your investment to reflect the performance of the STOXX® Europe 600 Index (the "Reference Index") which is designed to reflect the performance of shares of 600 companies across 18 European countries. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Not Disclosed 20/01/2009 | ||
Inception Date 20/01/2009 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
STOXX Europe 600 NR EUR | Morningstar DM Eur TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Xtrackers Stoxx Europe 600 UCITS ETF 1C | XSX6 | 01/05/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk A/S Class B | Healthcare | 3.68 |
ASML Holding NV | Technology | 3.10 |
Nestle SA | Consumer Defensive | 2.34 |
AstraZeneca PLC | Healthcare | 2.05 |
Shell PLC | Energy | 2.02 |
Increase Decrease New since last portfolio | ||
Xtrackers Stoxx Europe 600 UCITS ETF 1C | XSX6 |